The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity
epidemic is a major health concern worldwide. NAFLD—specifically its more advanced form …

The global outbreak of COVID-19 possesses serious challenges and adverse impacts for
patients with progression of chronic liver disease and has become a major threat to public …

The gut microbiome (GM) has emerged in the last few years as a main character in several
diseases. In pediatric oncological patients, GM has a role in promoting the disease …

Whether the alternated microbiota in the gut contribute to the risk of allograft rejection (AR)
and pulmonary infection (PI) in the setting of lung transplant recipients (LTRs) remains …

Liver transplantation as a treatment option for end-stage liver diseases is associated with a
relevant risk for complications. On the one hand, immunological factors and associated …

The present report summarizes the United States Department of Veterans Affairs (VA) field-
based meeting titled “Modulating microbiome-immune axis in the deployment-related …

Mycophenolate mofetil has an important role as immunosuppressive agent in solid organ
transplant recipients. Exposure to the active mycophenolic acid (MPA) can be monitored …

The intestinal microflora is extremely important, not only in the processes of absorption,
digestion and biosynthesis of vitamins, but also in shaping the immune and cognitive …

The clinical response to classical immunosuppressant drugs (cIMDs) is highly variable
among individuals. We performed a systematic review of published evidence supporting the …

Intrinsic metabolism shapes the immune environment associated with immune suppression
and tolerance in settings such as organ transplantation and cancer. However, little is known …